Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials
Prostaglandins, Leukotrienes and Essential Fatty Acids · 2023
DOI: 10.1016/j.plefa.2023.102572 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2023. Verfasst von Christos F Kelaiditis und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health Sciences, University of Roehampton, London, UK. Electronic address: kelaidic@roehampton.ac.uk. Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Fatty Acids, Omega-3. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
The omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic- (EPA), docosahexaenoic- (DHA) and docosapentaenoic acid (DPAn-3) are promising therapeutic options in reducing the severity of anxious and depressive symptoms. However, meta-analyses of randomised controlled trials (RCTs) yield mixed findings. This systematic review and meta-analysis reviewed the evidence and assessed the efficacy of EPA, DHA and DPAn-3 in reducing the severity of anxiety and depression with specific consideration to methodological complications unique to the field e.g., dose and ratio of omega-3 PUFAs and placebo composition. Random-effects meta-analysis of ten RCTs comprising 1426 participants revealed statistically significant reduction in depression severity with EPA-enriched interventions at proportions ≥ 60% of total EPA + DHA (SMD: -0.36; 95% CI: -0.68, -0.05; p = 0.02) (I2 = 86%) and EPA doses between ≥ 1 g/day and < 2 g/day (SMD: -0.43; 95% CI: -0.79, -0.07; p = 0.02) (I2 = 88%); however, EPA doses ≥ 2 g/day were not associated with significant therapeutic effects (SMD: -0.20; 95% CI: -0.48, 0.07; p = 0.14). Only one study reported significant reduction in anxiety severity with 2.1 g/day EPA (85.6% of total EPA + DHA), therefore meta-analysis was not possible. No trials administering DPAn-3 were identified. Visual examination of the funnel plot revealed asymmetry, suggesting publication bias and heterogeneity amongst the trials. These results support the therapeutic potential of EPA in depression at proportions ≥ 60% of total EPA + DHA and doses ≥ 1 g/day and < 2 g/day. The observed publication bias and heterogeneity amongst the trials reflect the need for more high-quality trials in this area with consideration to the unique nature of omega-3 PUFAs research, to more fully elucidate the therapeutic potential of EPA, DHA and DPAn-3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life and Health Sciences, University of Roehampton, London, UK. Electronic address: kelaidic@roehampton.ac.uk.
- School of Psychology, University of Roehampton, London, UK.
- School of Life and Health Sciences, University of Roehampton, London, UK.
Zitieren
APA
Kelaiditis, C. F., Gibson, E. L., & Dyall, S. C. (2023). Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids. https://doi.org/10.1016/j.plefa.2023.102572
Vancouver
Kelaiditis CF, Gibson EL, Dyall SC. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2023. doi:10.1016/j.plefa.2023.102572
BibTeX
@article{Kelaiditis2023,
author = {Kelaiditis, Christos F and Gibson, E Leigh and Dyall, Simon C},
title = {Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials},
journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
year = {2023},
doi = {10.1016/j.plefa.2023.102572}
}
EUVIMED